OPL, LCT, VHT - ASX healthcare stocks leveraging AI - Kalkine Media

July 16, 2022 10:00 AM AEST | By Aditi Sarkar
Follow us on Google News:

Highlights

  • Artificial Intelligence (AI) algorithms provide precise data to gain insight into care processes, treatment variability, diagnostics, and patient results
  • AI holds potential to reduce the margin of probable errors in medication
  • Opyl, Living Cell, and Volpara are some ASX healthcare stocks that utilise AI

Artificial intelligence (AI) is a  technology that enables machines to learn from past data and given information, makes sense of it, and uses this information to do various business tasks.

The healthcare industry is leveraging AI to gain advantages over traditional analytics methods and make clinical decisions. AI algorithms provide precise data to gain insights into care processes, treatment variability,  diagnostics, and patient results.

Let us discuss in brief some of the roles of AI in healthcare.

 

  • Through Customer service chatbots, patients can raise their queries regarding illness symptoms, appointments, and bill payments. This, in turn, reduces the workload of medical professionals.
  • Every healthcare organisation has a huge pile of critical data which needs proper and secure management. AI helps in the appropriate management and processing of these data.
  • The automation of redundant time-consuming tasks is another major role of AI in healthcare. It stamps out the need for integration and expensive downtimes.
  • AI holds potential to reduce the margin of probable errors in medication. Sometimes, even an extra dose of drug or medicine can be detrimental to a patient
  • Robots incorporated with cameras, surgical tools and required mechanical arms enhance doctors' knowledge, skills, and experience, creating a new form of surgery.
  • AI applications have algorithms that make it easier to interpret complex images to conduct analysis.

Let us dive into three healthcare stocks from the ASX that are leveraging AI.

Opyl Limited (ASX: OPL)

Opyl is steered by its mission to enhance health and wellness through its innovative digital platform. It provides professional guidance and access to emerging AI technologies for biopharma and healthcare organisations. The company’s services include:

  • Social media insights
  • Clinical trial recruitment platform

Living Cell Technologies (ASX: LCT)

Living Cell is a biotechnology company focused on the development and commercialisation of regenerative treatments. It addresses serious conditions in its product candidates by using the potential of cells and their receptors.

NTCELL is the company’s product candidate for treating Parkinson’s disease. It is a capsule coated with alginate and contains clusters of neonatal porcine choroid plexus cells.

In May, the company announced applying AI in its innovative research against Parkinson’s disease.

Volpara Health Technologies (ASX: VHT)

Volpara is one of the prominent global players in AI R&D (research and development) for the early detection of breast cancer. It has software that provides data and feedback to clinicians.

Recently, the company signed a contract with Radnet Management, Inc, a US-based company offering outpatient imaging services under which, Radnet will implement VHT’s Software throughout its organisation.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK